Filtros de búsqueda

Lista de obras de Michal Juraska

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

artículo científico publicado en 2017

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

scientific article published on 22 October 2020

Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial

artículo científico publicado en 2015

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2

artículo científico publicado en 2012

Sieve Analysis: Statistical Methods for Assessing Genotype-specific Vaccine Protection in Hiv-1 Efficacy Trials With Multivariate and Missing Genotypes ⬇️

doctoral thesis by Michal Juraska, University of Washington, 2012

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.

artículo científico publicado en 2017

TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25.

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda